QSAM Biosciences Overview
- Year Founded
-
2004

- Status
-
Acquired/Merged
- Employees
-
5

- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$125M
QSAM Biosciences General Information
Description
Telix QSAM Inc formerly QSAM Biosciences Inc is a clinical-stage novel radiopharmaceutical company. The company is developing treatments for bone cancer and related diseases.
Contact Information
Website
www.qsambio.comCorporate Office
- 9442 North Capital of Texas Highway, Plaza 1
- Suite 500
- Austin, TX 78759
- United States
Corporate Office
- 9442 North Capital of Texas Highway, Plaza 1
- Suite 500
- Austin, TX 78759
- United States
QSAM Biosciences Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
10. Merger/Acquisition | 03-May-2024 | $125M | Completed | Generating Revenue | ||
9. PIPE | 31-Mar-2023 | Completed | Generating Revenue | |||
8. 2PO | 17-May-2022 | Cancelled | Generating Revenue | |||
7. PIPE | 28-Jan-2021 | Completed | Generating Revenue | |||
6. Merger/Acquisition | 01-Nov-2018 | Completed | Generating Revenue/Not Profitable | |||
5. Reverse Merger | 19-Nov-2015 | Completed | Generating Revenue/Not Profitable | |||
4. Angel (individual) | 18-Jun-2015 | Completed | Startup | |||
3. Angel (individual) | 31-Jan-2015 | Completed | Startup | |||
2. Seed Round | 31-Oct-2014 | $1.31M | $1.66M | Completed | Startup | |
1. Seed Round | 14-Aug-2014 | $350K | $350K | Completed | Startup |
QSAM Biosciences Comparisons
Industry
Financing
Details
QSAM Biosciences Competitors (4)
One of QSAM Biosciences’s 4 competitors is Y-mAbs Therapeutics, a Formerly VC-backed company based in New York, NY.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Y-mAbs Therapeutics | Formerly VC-backed | New York, NY | ||||
Fusion Pharmaceuticals | Formerly VC-backed | Hamilton, Canada | ||||
Telix Pharmaceuticals | Corporation | North Melbourne, Australia | ||||
Novartis | Corporation | Basel, Switzerland |
QSAM Biosciences Signals
QSAM Biosciences Former Investors (15)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Alan Gelband | Angel (individual) | Minority | ||
Anpath Group | Corporation | Minority | ||
Bob Clifford | Angel (individual) | Minority | ||
Brett Conrad | Angel (individual) | Minority | ||
Checkmate Capital Group | Venture Capital | Majority |
QSAM Biosciences Investments & Acquisitions (5)
QSAM Biosciences’s most recent deal was a Corporate Asset Purchase with Agrarian Technologies (license to sell Agrarian's proprietary ABS bio-stimulant). The deal was made on 01-May-2019.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Agrarian Technologies (license to sell Agrarian's proprietary ABS bio-stimulant) | 01-May-2019 | Corporate Asset Purchase | Buildings and Property | ||
Organics By Gosh | 23-Jan-2019 | Merger/Acquisition | Agricultural Chemicals | ||
George B. Wittmer Associates | 13-Nov-2018 | Merger/Acquisition | Environmental Services (B2B) | ||
ERTH Products | 30-Sep-2017 | Merger/Acquisition | Other Agriculture | ||
Anpath Group | 19-Nov-2015 | Merger/Acquisition | Other Healthcare Services |
Affiliates
Subsidiaries (3)
Name | Industry | Location | Year Founded |
---|---|---|---|
Organics By Gosh | Elgin, TX | 1998 | |
ERTH Products | Tyrone, GA | 1995 | |
George B. Wittmer Associates | Green Cove Springs, FL | 1994 |
QSAM Biosciences FAQs
-
When was QSAM Biosciences founded?
QSAM Biosciences was founded in 2004.
-
Where is QSAM Biosciences headquartered?
QSAM Biosciences is headquartered in Austin, TX.
-
What is the size of QSAM Biosciences?
QSAM Biosciences has 5 total employees.
-
What industry is QSAM Biosciences in?
QSAM Biosciences’s primary industry is Biotechnology.
-
Is QSAM Biosciences a private or public company?
QSAM Biosciences is a Private company.
-
What is the current valuation of QSAM Biosciences?
The current valuation of QSAM Biosciences is
. -
What is QSAM Biosciences’s current revenue?
The current revenue for QSAM Biosciences is
. -
How much funding has QSAM Biosciences raised over time?
QSAM Biosciences has raised $5.3M.
-
Who are QSAM Biosciences’s investors?
Alan Gelband, Anpath Group, Bob Clifford, Brett Conrad, and Checkmate Capital Group are 5 of 15 investors who have invested in QSAM Biosciences.
-
Who are QSAM Biosciences’s competitors?
Y-mAbs Therapeutics, Fusion Pharmaceuticals, Telix Pharmaceuticals, and Novartis are competitors of QSAM Biosciences.
-
When was QSAM Biosciences acquired?
QSAM Biosciences was acquired on 03-May-2024.
-
Who acquired QSAM Biosciences?
QSAM Biosciences was acquired by Telix Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »